Atlas Trials

Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer

Clinical trial NCT03211416 · COMPLETED

Trial details

NCT number
NCT03211416
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Adult Hepatocellular CarcinomaChild-Pugh Class AStage III Hepatocellular CarcinomaStage IIIA Hepatocellular CarcinomaStage IIIB Hepatocellular CarcinomaStage IIIC Hepatocellular CarcinomaStage IV Hepatocellular CarcinomaStage IVA Hepatocellular CarcinomaStage IVB Hepatocellular Carcinoma
Start date
2017-12-07
Primary completion
2023-03-07
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.